SAN DIEGO--(BUSINESS WIRE)--Metabasis Therapeutics (Nasdaq:MBRX), announced today that Dr. Paul Laikind, president and chief executive officer, will present at two investor conferences in February. Dr. Laikind is expected to provide an overview of the Company and its product candidates at each conference. The Company’s presentations will be webcast.
